SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 9.79 |
| Enterprise Value ($M) | 5.67 |
| Book Value ($M) | 6.05 |
| Book Value / Share | 1.99 |
| Price / Book | 1.62 |
| NCAV ($M) | 0.65 |
| NCAV / Share | 0.21 |
| Price / NCAV | 15.00 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -2.32 |
| Return on Assets (ROA) | -2.56 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 1.26 |
| Current Ratio | 1.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 7.84 |
| Assets | 13.24 |
| Liabilities | 7.19 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.89 |
| Operating Income | -18.42 |
| Net Income | -21.65 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -17.09 |
| Cash from Investing | -0.20 |
| Cash from Financing | 16.60 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Armistice Capital, Llc | 9.99 | ||
| 13G/A | KfW | 4.40 | -99.93 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 16,113 | 44,761 | 36.00 | |
| 6,044 | 34,510 | 17.51 | |
| 7,366 | 37,029 | 19.89 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| MRKR – Marker Therapeutics, Inc. | MTEX – Mannatech, Incorporated |
| MTVA – MetaVia Inc. | NAGE – Niagen Bioscience, Inc. |
| NATR – Nature's Sunshine Products, Inc. |
Financial data and stock pages provided by
Fintel.io